Dana Investment Advisors’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Sell
918,344
-14,873
-2% -$176K 0.32% 67
2026
Q1
$8.77M Sell
933,217
-75,308
-7% -$674K 0.26% 92
2025
Q4
$8.17M Buy
1,008,525
+419,429
+71% +$4.58M 0.24% 88
2025
Q3
$8.37M Buy
589,096
+24,099
+4% +$318K 0.25% 91
2025
Q2
$7.37M Buy
564,997
+25,993
+5% +$357K 0.24% 106
2025
Q1
$8.03M Sell
539,004
-13,871
-3% -$238K 0.29% 82
2024
Q4
$10M Buy
552,875
+148,160
+37% +$2M 0.33% 64
2024
Q3
$5.44M Buy
404,715
+345
+0.1% +$5.09K 0.18% 160
2024
Q2
$5.6M Buy
404,370
+104,136
+35% +$1.65M 0.19% 149
2024
Q1
$5.62M Buy
+300,234
New +$6M 0.19% 151

Other funds holding CCRN

Dana Investment Advisors's CCRN Position: Q2 2026 in Review

Dana Investment Advisors reduced its Cross Country Healthcare (CCRN) stake by 1.6% in Q2 2026, selling an estimated $176K and leaving 918,344 shares worth $12.1M. The position accounts for 0.32% of the portfolio, ranked #67.

Dana Investment Advisors first reported a position in CCRN in Q1 2024 and has held it in 10 quarters since. 150 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • Dana Investment Advisors held 918,344 shares of Cross Country Healthcare worth $12.1M as of Q2 2026.
  • Dana Investment Advisors sold 14,873 Cross Country Healthcare shares in Q2 2026, an estimated $176K.
  • Cross Country Healthcare made up 0.32% of Dana Investment Advisors's portfolio in Q2 2026, its #67 holding.
  • Dana Investment Advisors first reported a position in Cross Country Healthcare in Q1 2024 and has held it in 10 quarters since.
  • 150 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.